The limitations of using randomised controlled trials as a basis for developing treatment guidelines

Evidence-Based Mental Health

Volumn 21, Issue 1, 2018, Pages 4-6

  Mulder, Roger ^a,b   Singh, Ajeet B ^a,c   Hamilton, Amber ^a,d,e,f   Das, Pritha ^a,d,e,f   Outhred, Tim ^a,d,e,f   Morris, Grace ^a,d,e,f   Bassett, Darryl ^a,g   Baune, Bernhard T ^a,h   Berk, Michael ^a,c,i   Boyce, Philip ^a,e   Lyndon, Bill ^a,e,j,k   Parker, Gordon ^a,l,m   Malhi, Gin S ^a,d,f  

^a Mood Assessment and Classification (MAC) Committee   (Australia)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c DEAKIN UNIVERSITY   (Australia)

^d Northern Sydney Local Health District ^*  (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f ROYAL NORTH SHORE HOSPITAL   (Australia)

^g UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^h UNIVERSITY OF ADELAIDE   (Australia)

ⁱ UNIVERSITY OF MELBOURNE   (Australia)

^j Northside Clinic   (Australia)

^k Northside Group Hospitals   (Australia)

^l UNIVERSITY OF NEW SOUTH WALES   (Australia)

^m BLACK DOG INSTITUTE   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL DECISION MAKING; HUMAN; PRACTICE GUIDELINE; PSYCHIATRY; RANDOMIZED CONTROLLED TRIAL (TOPIC); STANDARDS;

CLINICAL DECISION-MAKING; HUMANS; PRACTICE GUIDELINES AS TOPIC; PSYCHIATRY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85034019064     PISSN: 13620347     EISSN: None     Source Type: Journal    
DOI: 10.1136/eb-2017-102701     Document Type: Article

References (20)

1. Malhi GS, Bassett D, Boyce P, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry 2015;49:1087-206.
2. Cartwright N. A philosopher's view of the long road from RCTs to effectiveness. Lancet 2011;377:1400-1.
3. Mulder RT, Frampton C, Joyce PR, et al. Randomized controlled trials in psychiatry. Part II: their relationship to clinical practice. Aust N Z J Psychiatry 2003;37:265-9.
4. Chan AW, Hróbjartsson A, Haahr MT, et al. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 2004;291:2457-65.
5. Barber S, Cipriani A. Lessons learned from Restoring Study 329: transparent reporting, open databases and network meta-analyses as the way forward. Aust N Z J Psychiatry 2017;51:407-9.
6. De Angelis C, Drazen JM, Frizelle FA, et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Lancet 2004;364:911-2.
7. Scott A, Rucklidge JJ, Mulder RT. Is mandatory prospective trial registration working to prevent publication of unregistered trials and selective outcome reporting? An observational study of five psychiatry Journals that mandate prospective clinical trial registration. PLoS One 2015;10:e0133718.
8. Bradley HA, Rucklidge JJ, Mulder RT. A systematic review of trial registration and selective outcome reporting in psychotherapy randomized controlled trials. Acta Psychiatr Scand 2017;135:65-77.
9. Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 1996;276:637-9.
10. Han C, Kwak KP, Marks DM, et al. The impact of the CONSORT statement on reporting of randomized clinical trials in psychiatry. Contemp Clin Trials 2009;30:116-22.
11. Tungaraza T, Poole R. Influence of drug company authorship and sponsorship on drug trial outcomes. Br J Psychiatry 2007;191:82-3.
12. Dragioti E, Dimoliatis I, Fountoulakis KN, et al. A systematic appraisal of allegiance effect in randomized controlled trials of psychotherapy. Ann Gen Psychiatry 2015;14:25.
13. Lundh LG, Petersson T, Wolgast M. The neglect of treatment-construct validity in psychotherapy research: a systematic review of comparative RCTs of psychotherapy for borderline personality disorder. BMC Psychol 2016;4:44.
14. Dickersin K, Chan S, Chalmers TC, et al. Publication bias and clinical trials. Control Clin Trials 1987;8:343-53.
15. Shapiro SH, Weijer C, Freedman B. Reporting the study populations of clinical trials. Clear transmission or static on the line? J Clin Epidemiol 2000;53:973-9.
16. Rothwell PM. External validity of randomised controlled trials: "to whom do the results of this trial apply?". Lancet 2005;365:82-93.
17. Edlund MJ, Overall JE, Rhoades HM. Beta, or type II error in psychiatric controlled clinical trials. J Psychiatr Res 1985;19:563-7.
18. Geddes JR, Cipriani A. Time to abandon placebo control in pivotal phase III trials? World Psychiatry 2015;14:306-7.
19. Cipriani A, Zhou X, Del Giovane C, et al. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. Lancet 2016;388:881-90.
20. Leucht S, Chaimani A, Cipriani AS, et al. Network meta-analyses should be the highest level of evidence in treatment guidelines. Eur Arch Psychiatry Clin Neurosci 2016;266:477-80.